Technical Bulletins

Jump To: 2024 | 2023 | 2022 | 2021 | 2020 | 2019

2024 Technical Bulletins

  • Sending out SARS-Cov-2 Nucleocapsid Total Ab, Qualitative and SARS-Cov-2 Spike Total Ab, Semi-Quantitative Testing

  • Replacement of the Melanoma NGS Profile

  • New Gram-Negative Bacillus Susceptibility Panels

  • Outsourcing Blood Cultures for Fungi and Acid Fast Bacilli (AFB)

  • Acceptable Fecal Occult Blood Collection Devices

  • Procalcitonin Biomarker for Serious Infections – Update #1

  • Reflex test algorithms for Hepatitis B and Hepatitis C

  • Aerococcus Susceptibility to Antimicrobics

  • Rapid PCR Testing for Mycobacterium tuberculosis

    View →

  • Pyrazinamide (PZA) Testing for Mycobacterium tuberculosis

    View →

  • Sexually Transmitted Infection Testing in Young Patients

  • Legionella Testing by Urine Antigen & Legionella Culture

  • Sending Out Mitochondrial M2 Antibody Testing

    View →

  • Medical Device Recall: BIOFIRE FILMARRAY GI Panel

    View →

2023 Technical Bulletins

  • Medical Device Recall: BIOFIRE FILMARRAY Pneumonia Panel

    View →

  • No Longer Covered: Respiratory Panel & Stool GI Pathogen Panel

    View →

  • HCV Panels simplify compliance with Public Health recommendations

    View →

  • Discontinuation of DNA/RNA Shield Collection Media and DLS Central Testing for COVID-19 on ThermoFisher High-Throughput Platform

    View →

  • Update to HSV Serology Testing and STI Panels

    View →

  • Updated Interpretive Comments for QuantiFERON-TB Gold Plus

    View →

  • Testing for Sexually Transmitted Infections - Update

    View →

  • Testing for Sexually Transmitted Infections - Expansion

    View →

  • New Testing for Carbapenemase Genes Improves Inpatient Management

    View →

  • SARS-CoV-2 EUA Fact Sheets for Providers

    View →

2022 Technical Bulletins

  • Testing Support for 2022-2023 Respiratory Disease Season

    View →

  • HIV Antigen/Antibody Screen Test Provides Analyte-Specific Results

    View →

  • QuantiFeron IGRA Demonstrates Uncertainty Around the Cutoff

    View →

  • Outsourcing Ova and Parasite Test for Intestinal Parasites

    View →

  • Medicare Coverage Restriction for Combination Orders of Tumor Antigen CA 15-3 (TC 207) and CA 27.29 (TC 4659)

    View →

  • Taxonomy Changes in the MALDI-TOF/MS Database

    View →

  • Interpretation of SARS-CoV-2 (COVID-19) PCR Presumptive Positive

    View →

2021 Technical Bulletins

  • Remove race from eGFR Calculation

    View →

  • RAPIDPoint 500e Blood Gas Analyzer

    View →

  • Suppression of Clostridioides difficile Result in Multiplex GI Panel

    View →

  • Temporary Discontinuation of VerifyNow

    View →

  • Update: Kappa and Lambda Light Chains, Free testing performed in house

    View →

  • Fecal Lactoferrin Replacing WBC-Stool (Fecal Leukocytes) to Indicate Inflammation in the Bowel

    View →

  • Discontinuation of Hemoccult Fecal Occult Blood Test

    View →

  • Updated Albumin / Globulin Ratio Reference Range

    View →

  • Tissue Oncology Testing is available in CARE*Link

    View →

  • Oncology Testing Supports QMC Precision Medicine Program

    View →

  • Discontinuation of In-house Hepatitis B envelope Ag and Ab Testing

    View →

2020 Technical Bulletins

  • Updated Kappa and Lambda Light Chains, Free

    View →

  • The VDRL Test Performed on CSF will Automatically Reflex to Provide a Titer

    View →

  • Discontinuation of Streptozyme Testing

    View →

  • Antimicrobic Susceptibility Interpretations

    View →

  • Change in Ordering Practice for Outpatient Transfusions

    View →

  • Tests Unavailable for Add-on Requests

    View →

  • Preliminary bacterial identifications are now reported from positive blood culture by MALDI-TOF/MS

    View →

  • Troponin T Generation 5 STAT Assay

    View →

  • Rapid Multiplex Pneumonia Panel Now Available at Central

    View →

2019 Technical Bulletins

  • Local testing for procalcitonin is available in Guam beginning December 17, 2019

    View →

  • Update on Testing for Helicobacter Pylori Infections

    View →

  • Rapid PCR replaces Antigen Testing for Influenza in Guam

    View →

  • Availability of QuantiFERON-TB Gold Plus in Guam and Saipan

    View →

  • Update for Urinalysis Result Reporting

    View →

  • Quantitative CMV testing by qPCR available at DLS Central Laboratory

    View →

  • Clostridioides (Clostridium) difficile screening now available at Queen’s Punchbowl and Queen’s West Oahu laboratories

    View →

  • New Bood Culture Instruments and Bottles

    View →

  • Updated Fluoroquinolone Susceptibility Interpretation

    View →

  • Cefazolin Susceptibilities for Uncomplicated UTI Now Available

    View →

  • Genotyping for HIV Drug Resistance now includes Integrase Inhibitors

    View →

  • Routine and Special Circumstance use of Throat Culture

    View →

  • Next Generation Hepatitis B Surface Antigen Assay

    View →

  • Pneumococcus Testing by Rapid Antigen Compliments Laboratory Approach to Community-Acquired Pneumonia (CAP) and Meningitis

    View →

  • Update to Protime INR reporting range

    View →

  • Reflex test algorithms for Hepatitis B and Hepatitis C

    View →